Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival.

IF 5.3 2区 医学 Q1 ONCOLOGY JCO precision oncology Pub Date : 2025-01-01 Epub Date: 2025-01-07 DOI:10.1200/PO-24-00603
Ying Li, Youliang Weng, Zongwei Huang, Lishui Wu, Siqi Xu, Yingjie Xie, Haolan Li, Jinghua Lai, Dan Hu, Sufang Qiu
{"title":"Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival.","authors":"Ying Li, Youliang Weng, Zongwei Huang, Lishui Wu, Siqi Xu, Yingjie Xie, Haolan Li, Jinghua Lai, Dan Hu, Sufang Qiu","doi":"10.1200/PO-24-00603","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Chronoradiobiology has emerged as a potential field of study with therapeutic implications for cancer treatment. We aimed to investigate the association between radiation chronotherapy and the efficacy and toxicity of patients with nasopharyngeal carcinoma (NPC).</p><p><strong>Patients and methods: </strong>Patients with nonmetastatic NPC treated with intensity-modulated radiotherapy in Fujian Cancer Hospital between January 2017 and December 2019 were included. Propensity score matching (PSM) with 1:1:1 was used to account for selection bias. Cox regression analysis was performed to explore the impact of radiotherapy timing on patient survival. Sensitivity analysis was implemented to determine the size and directional stability.</p><p><strong>Results: </strong>One thousand forty patients met study inclusion criteria and 332 patients were included in a PSM cohort. In the unmatched cohort analysis, morning radiotherapy exhibited a significantly superior overall survival (OS) outcome (hazard ratio [HR], 0.60 [95% CI, 0.40 to 0.91], adjusted log-rank <i>P</i> = .028) than the afternoon one. After PSM analysis, it was observed that individuals undergoing radiotherapy in the afternoon group (HR, 5.88 [95% CI, 2.55 to 13.58], adjusted log-rank <i>P</i> = .004) and the night group (HR, 4.81 [95% CI, 1.91 to 12.11], adjusted log-rank <i>P</i> = .018) displayed a tendency toward shorter OS compared with the morning group. No significant differences in acute treatment-related adverse effects were observed among the three groups. Morning radiotherapy demonstrated consistent robustness in the multivariable analysis, thereby establishing an association with higher OS. The directionality of the effect size was consistent across sensitivity analysis.</p><p><strong>Conclusion: </strong>These results underscore the potential benefits of scheduling radiotherapy in the morning for NPC management, although prospective studies are needed to confirm these findings.</p>","PeriodicalId":14797,"journal":{"name":"JCO precision oncology","volume":"9 ","pages":"e2400603"},"PeriodicalIF":5.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11723500/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO precision oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/PO-24-00603","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Chronoradiobiology has emerged as a potential field of study with therapeutic implications for cancer treatment. We aimed to investigate the association between radiation chronotherapy and the efficacy and toxicity of patients with nasopharyngeal carcinoma (NPC).

Patients and methods: Patients with nonmetastatic NPC treated with intensity-modulated radiotherapy in Fujian Cancer Hospital between January 2017 and December 2019 were included. Propensity score matching (PSM) with 1:1:1 was used to account for selection bias. Cox regression analysis was performed to explore the impact of radiotherapy timing on patient survival. Sensitivity analysis was implemented to determine the size and directional stability.

Results: One thousand forty patients met study inclusion criteria and 332 patients were included in a PSM cohort. In the unmatched cohort analysis, morning radiotherapy exhibited a significantly superior overall survival (OS) outcome (hazard ratio [HR], 0.60 [95% CI, 0.40 to 0.91], adjusted log-rank P = .028) than the afternoon one. After PSM analysis, it was observed that individuals undergoing radiotherapy in the afternoon group (HR, 5.88 [95% CI, 2.55 to 13.58], adjusted log-rank P = .004) and the night group (HR, 4.81 [95% CI, 1.91 to 12.11], adjusted log-rank P = .018) displayed a tendency toward shorter OS compared with the morning group. No significant differences in acute treatment-related adverse effects were observed among the three groups. Morning radiotherapy demonstrated consistent robustness in the multivariable analysis, thereby establishing an association with higher OS. The directionality of the effect size was consistent across sensitivity analysis.

Conclusion: These results underscore the potential benefits of scheduling radiotherapy in the morning for NPC management, although prospective studies are needed to confirm these findings.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
优化鼻咽癌放疗时间:放疗计划对生存的影响。
目的:时间放射生物学已经成为一个潜在的研究领域,具有治疗癌症的意义。我们的目的是探讨放射时间疗法与鼻咽癌(NPC)患者的疗效和毒性之间的关系。患者和方法:纳入2017年1月至2019年12月福建省肿瘤医院接受调强放疗的非转移性鼻咽癌患者。采用1:1:1的倾向得分匹配(PSM)来解释选择偏差。采用Cox回归分析探讨放疗时间对患者生存的影响。采用灵敏度分析确定了粒径和方向稳定性。结果:1440例患者符合研究纳入标准,332例患者被纳入PSM队列。在非匹配队列分析中,上午放疗显示出明显优于下午放疗的总生存(OS)结果(风险比[HR], 0.60 [95% CI, 0.40至0.91],校正log-rank P = 0.028)。经PSM分析,观察到下午组(HR, 5.88 [95% CI, 2.55 ~ 13.58],校正log-rank P = 0.004)和夜间组(HR, 4.81 [95% CI, 1.91 ~ 12.11],校正log-rank P = 0.018)接受放疗的个体比早晨组有更短的OS的趋势。三组间急性治疗相关不良反应无显著差异。早间放疗在多变量分析中表现出一致的稳健性,从而与较高的OS建立了关联。效应量的方向性在敏感性分析中是一致的。结论:这些结果强调了在鼻咽癌治疗中安排上午放疗的潜在益处,尽管需要前瞻性研究来证实这些发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.10
自引率
4.30%
发文量
363
期刊最新文献
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H. Precision-Guided Durable Response From Venetoclax With Decitabine in a Patient With a Metastatic Refractory IDH2-Mutant Cholangiocarcinoma. ALK-Rearranged Non-Small Cell Lung Cancer Presenting as a Large Mediastinal Mass: A Case Report. Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1